glp 1 glucagon dual agonist Discovery of novel OXM-based glucagon-like peptide (GLP-1)/glucagon receptor agonists Beyond metabolic benefits: The underexplored

56 : 407412 Goodwin FK, Jamison KR

Anti-aging context declining GH with age drives much of the longevity-oriented interest, but using these peptides for anti-aging purposes remains investigational and is not an FDA-approved indication

It has demonstrated a range of anti-oxidative and anti-apoptotic effects in both in vitro and in vivo investigations

Transmission electron microscope observation The cells in the logarithmic phase were cultured on a wall for one day and then exposed to HT, followed by rinsing the cells with PBS, adding electron microscope fixative (Servicebio, Wuhan, China) and fixing them for 6 min at 37 C